Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
Sufentanil NanoTab PCA System (ARX-01)
Also known as: Sublingual Sufentanil NanoTabs
print preview
bookmark
share with colleague
General Information
Company
AcelRx Pharmaceuticals Inc.
Description
Pre-programmed, handheld device that delivers a sublingual formulation of sufentanil, a synthetic opioid analgesic
Molecular Target
Opioid receptor (OPR)
Mechanism of Action
Opioid receptor agonist
Latest Stage of Development
Phase III
Indication
Pain
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy